313 related articles for article (PubMed ID: 23962263)
21. Adherence to topical therapies in actinic keratosis: A literature review.
Foley P; Stockfleth E; Peris K; Basset-Seguin N; Cerio R; Antonio Sanches J; Guillen C; Farrington E; Lebwohl M
J Dermatolog Treat; 2016 Nov; 27(6):538-545. PubMed ID: 27161045
[TBL] [Abstract][Full Text] [Related]
22. A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis.
Stockfleth E; Peris K; Guillen C; Cerio R; Basset-Seguin N; Foley P; Sanches J; Culshaw A; Erntoft S; Lebwohl M
Int J Dermatol; 2015; 54(5):509-15. PubMed ID: 25865875
[TBL] [Abstract][Full Text] [Related]
23. Ingenol mebutate gel for actinic keratosis: the link between quality of life, treatment satisfaction, and clinical outcomes.
Augustin M; Tu JH; Knudsen KM; Erntoft S; Larsson T; Hanke CW
J Am Acad Dermatol; 2015 May; 72(5):816-21. PubMed ID: 25770879
[TBL] [Abstract][Full Text] [Related]
24. Community-Based Practice Variations in Topical Treatment of Actinic Keratoses.
Storer M; Zhu Z; Sokil M; Ford M; Neugebauer R; Asgari MM
JAMA Dermatol; 2017 May; 153(5):468-470. PubMed ID: 28384712
[TBL] [Abstract][Full Text] [Related]
25. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
Ulrich M; Alarcon I; Malvehy J; Puig S
Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
[TBL] [Abstract][Full Text] [Related]
26. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
Bettencourt MS
J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
[TBL] [Abstract][Full Text] [Related]
27. Patient-reported outcomes of topical therapies in actinic keratosis: A systematic review.
Grada A; Feldman SR; Bragazzi NL; Damiani G
Dermatol Ther; 2021 Mar; 34(2):e14833. PubMed ID: 33527673
[TBL] [Abstract][Full Text] [Related]
28. Patient-reported outcomes in topical field treatment of actinic keratosis in Swedish and Danish patients.
Norrlid H; Norlin JM; Holmstrup H; Malmberg I; Sartorius K; Thormann H; Jemec GBE; Ragnarson Tennvall G
J Dermatolog Treat; 2018 Feb; 29(1):68-73. PubMed ID: 28658998
[TBL] [Abstract][Full Text] [Related]
29. Lack of activity of betulin-based Oleogel-S10 in the treatment of actinic keratoses: a randomized, multicentre, placebo-controlled double-blind phase II trial.
Pflugfelder A; Andonov E; Weide B; Dirschka T; Schempp C; Stockfleth E; Stratigos A; Krüger-Krasagakis S; Bauer J; Garbe C; Eigentler TK
Br J Dermatol; 2015 Apr; 172(4):926-32. PubMed ID: 25124939
[TBL] [Abstract][Full Text] [Related]
30. Topical treatment of actinic keratoses with piroxicam 1% gel: a preliminary open-label study utilizing a new clinical score.
Campione E; Diluvio L; Paternò EJ; Chimenti S
Am J Clin Dermatol; 2010; 11(1):45-50. PubMed ID: 20000874
[TBL] [Abstract][Full Text] [Related]
31. Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update.
Vale SM; Hill D; Feldman SR
Pharmacoeconomics; 2017 Feb; 35(2):177-190. PubMed ID: 27785771
[TBL] [Abstract][Full Text] [Related]
32. Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study.
Babino G; Diluvio L; Bianchi L; Orlandi A; Di Prete M; Chimenti S; Milani M; Campione E
Curr Med Res Opin; 2016 Aug; 32(8):1345-9. PubMed ID: 27046744
[TBL] [Abstract][Full Text] [Related]
33. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
Galitzer BI
J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
[TBL] [Abstract][Full Text] [Related]
34. Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders.
Moore AY
J Dermatolog Treat; 2009; 20(6):328-35. PubMed ID: 19954388
[TBL] [Abstract][Full Text] [Related]
35. Variables in Cryosurgery Technique Associated With Clearance of Actinic Keratosis.
Berman B; Shabbir AQ; MacNeil T; Knudsen KM
Dermatol Surg; 2017 Mar; 43(3):424-430. PubMed ID: 28002105
[TBL] [Abstract][Full Text] [Related]
36. Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study.
Schlaak M; Simon JC
J Dtsch Dermatol Ges; 2010 Mar; 8(3):174-8. PubMed ID: 19889001
[TBL] [Abstract][Full Text] [Related]
37. Randomized, vehicle-controlled trials of topical 5-fluorouracil therapy for actinic keratosis treatment: an overview.
Rahvar M; Lamel SA; Maibach HI
Immunotherapy; 2012 Sep; 4(9):939-45. PubMed ID: 23046237
[TBL] [Abstract][Full Text] [Related]
38. Relative efficacy of 5-fluorouracil compared with other treatments among patients with actinic keratosis: A network meta-analysis.
Wu Y; Tang N; Cai L; Li Q
Dermatol Ther; 2019 May; 32(3):e12822. PubMed ID: 30638294
[TBL] [Abstract][Full Text] [Related]
39. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
Rivers JK; McLean DI
Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562
[TBL] [Abstract][Full Text] [Related]
40. Management of benign skin lesions commonly affecting the face: actinic keratosis, seborrheic keratosis, and rosacea.
Brodsky J
Curr Opin Otolaryngol Head Neck Surg; 2009 Aug; 17(4):315-20. PubMed ID: 19465852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
